Chondroitin sulfate has long been recognized as an essential ingredient for joint health and mobility. But not all chondroitin sulfates are equal. MyCondro™ is the next generation of chondroitin sulfate.
MyCondro™, the first non-animal chondroitin sulfate produced via fermentation, is fundamentally transforming what’s possible in joint support. Indeed, MyCondro™ delivers superior efficacy, purity, and consistency that traditional animal-derived sources simply cannot match.
The Bioavailability Breakthrough
The most compelling advantage of MyCondro™ lies in its molecular structure. With a low molecular weight of less than 10 kDa, MyCondro™ achieves +45% greater bioavailability than bovine chondroitin sulfate after just 48 hours.
This isn’t just a marginal improvement; it’s a game-changer for formulation efficiency.
MyCondro™ delivers efficacy at lower dosages, clinically validated at just 600mg. It enables easier formulation for manufacturers and delivers better results for consumers with smaller, more convenient doses. The product offers flexibility to combine with other ingredients without bulky formulations.
In contrast, animal-derived chondroitin sulfate has a high molecular weight (20-50 kDa), leading to poor absorption and requiring higher doses to achieve comparable results.
A Clinically Backed Chondroitin Sulfate
MyCondro™ isn’t just theoretically superior; it’s clinically proven. The ingredient demonstrates improvements of +11 points in knee function and reductions of -12 points in knee pain, both versus placebo. Additionally, it shows significant reductions in inflammation, with measurable decreases in CRP and ESR markers.
These results demonstrate that MyCondro™ delivers tangible benefits for mobility and joint health, backed by peer-reviewed science.
Superior Purity with an Ethical Advantage
MyCondro™ represents excellence by design. It is 100% pure chondroitin sulfate with consistent, reproducible sulfation patterns. The controlled fermentation process ensures batch-to-batch consistency, and the product is free from contaminants and biological variation. Transparent traceability provides zero risk of mixed sources.
Animal-derived chondroitin sulfate, by contrast, suffers from inherent limitations. It exhibits biological variation depending on animal type and source, and may pose contamination risks from mixed sources. Animal-derived versions contain keratan sulfate, which compromises product efficacy, and may include traces of DNA and proteins that can trigger allergic reactions. Additionally, solvent and heavy metal residues from processing remain a concern.
Beyond performance, MyCondro™ addresses growing consumer demands. The ingredient is 100% vegan—suitable for all dietary preferences. It is religiously compliant with transparent sourcing and no mixed animal sources. MyCondro™ is produced sustainably through fermentation, a more environmentally responsible approach than traditional methods. The product is allergen-safe with no animal-derived proteins or DNA.
Animal-derived chondroitin sulfate cannot offer these benefits, limiting its appeal to increasingly conscious consumers.
MyCondro™ is for Everyone
MyCondro™ is the ideal choice for athletes, where superior bioavailability supports peak performance and recovery. Active consumers benefit from efficient dosing that fits busy lifestyles. Proactive health users appreciate the low-dose efficacy for long-term joint maintenance. Aging populations gain from clinically proven support for mobility and reduced inflammation. People under physical load benefit from sustained joint support for demanding activities.
Discover MyCondro™
Chondroitin sulfate has been traditionally sourced from animals, but concerns over cross-contamination and manufacturing processes, as driven demand for a non-animal source of this key nutrient. Gnosis by Lesaffre is proud to fulfill this demand with its revolutionary ingredient MyCondro™.
